You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-AIF antibody (ab2086)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-AIF antibody
See all AIF products (13) ...

Description

Rabbit polyclonal to AIF

Tested applications

WBmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic peptide: KDGEQHEDLNEVAK, corresponding to amino acids 593 - 606 of Human AIF.

KDGEQHEDLNEVAK

Positive control

K562 whole cell lysate.

General notes

Apoptosis Inducing Factor.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

PBS with 0.02% sodium azide

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - AIF antibody (ab2086)Western blot - AIF antibody (ab2086) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab2086 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: Use at a concentration of 0.25 - 1 µg/ml. Detects a band of approximately 67 kDa (predicted molecular weight: 67 kDa).
This antibody can be used with studies using ab1998.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Probable oxidoreductase that has a dual role in controlling cellular life and death; during apoptosis, it is translocated from the mitochondria to the nucleus to function as a proapoptotic factor in a caspase-independent pathway, while in normal mitochondria, it functions as an antiapoptotic factor via its oxidoreductase activity. The soluble form (AIFsol) found in the nucleus induces 'parthanatos' i.e., caspase-independent fragmentation of chromosomal DNA. Interacts with EIF3G,and thereby inhibits the EIF3 machinery and protein synthesis, and activates casapse-7 to amplify apoptosis. Plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Binds to DNA in a sequence-independent manner.

Involvement in disease

Defects in AIFM1 are the cause of combined oxidative phosphorylation deficiency type 6 (COXPD6) [MIM:300816]. It is a mitochondrial disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting.

Sequence similarities

Belongs to the FAD-dependent oxidoreductase family.

Post-translational
modifications

Under normal conditions, a 54-residue N-terminal segment is first proteolytically removed during or just after translocation into the mitochondrial intermembrane space (IMS) by the mitochondrial processing peptidase (MPP) to form the inner-membrane-anchored mature form (AIFmit). During apoptosis, it is further proteolytically processed at amino-acid position 101 leading to the generation of the mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis in a caspase-independent manner.

Cellular localization

Mitochondrion intermembrane space. Mitochondrion inner membrane. Cytoplasm. Nucleus. Cytoplasm > perinuclear region. Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of an inner-membrane-anchored mature form (AIFmit). During apoptosis, further proteolytic processing leads to a mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis. Colocalizes with EIF3G in the nucleus and perinuclear region.

Target information above from: UniProt accessionO95831 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • mitochondrial antibody
  • AIFM1 antibody
  • AIFM1_HUMAN antibody
  • Apoptosis inducing factor 1, mitochondrial antibody
  • Apoptosis inducing factor antibody
  • Apoptosis inducing factor, mitochondrion associated, 1 antibody
  • Apoptosis-inducing factor 1 antibody
  • COXPD6 antibody
  • Harlequin antibody
  • Hq antibody
  • mAIF antibody
  • MGC111425 antibody
  • MGC5706 antibody
  • MSA09 antibody
  • PDCD 8 antibody
  • PDCD8 antibody
  • Programmed cell death 8 (apoptosis inducing factor) antibody
  • Programmed cell death 8 antibody
  • Programmed cell death 8 isoform 1 antibody
  • Programmed cell death 8 isoform 2 antibody
  • Programmed cell death 8 isoform 3 antibody
  • Programmed cell death protein 8 antibody
  • Programmed cell death protein 8 mitochondrial antibody
  • Programmed cell death protein 8 mitochondrial precursor antibody
  • Striatal apoptosis inducing factor antibody
see all

Anti-AIF antibody images:

  Western blot - AIF antibody (ab2086)

Western blot - AIF antibody (ab2086)

All lanes : Anti-AIF antibody (ab2086) at 1 µg/ml

Lane 1 : K562 cell lysate
Lane 2 : Mouse liver tissue lysate
Lane 3 : Rat liver tissue lysate


Predicted band size : 67 kDa
Observed band size : 67 kDa

References for Anti-AIF antibody (ab2086)

ab2086 has not yet been referenced specifically in any publications.

Publishing research using ab2086? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"